| Abstract | Analysis of national data from the health ministry programme of reduction of the cardiovascular risks (2002-2005) shows a high frequency of cardiovascular disease and cardiovascular risk factors in the general population. It is of interest to analyse these data in relation to the practice of rheumatology. In addition, the frequency of cardiovascular pathologies is higher in patients with rheumatoid arthritis and spondylarthropothy. These notions are also very important since these two populations are often treated with non-steroidal anti-inflammatory drugs for a long duration. General knowledge shown in this article concerning the cardiovascular risk factors and co-morbidities in the patients with rheumatic pathologies allows, within the context of a therapeutic decisional strategy in rheumatology, a better estimation of the individual benefit/risk ratio of each prescription and more particularly that of non-steroidal anti-inflammatory drugs. |
| Authors | Philippe Bertin
(Affiliation: Service de Thérapeutique et de Rhumatologie, CHU Dupuytren, Limoges 87000. philippe.bertin at chu-limoges.fr)
|
| Journal | Presse médicale (Paris, France : 1983)
(Presse Med)
Vol. 35
Issue 9 Spec No 1
Pg. 1S5-9
(Sep 2006)
ISSN: 0755-4982 France |
| Vernacular Title | Quelle est la fréquence des facteurs de risque et co-morbidités cardiovasculaires chez les patients atteints de maladie rhumatismale? |
| PMID | 17078590
(Publication Type: Comparative Study, English Abstract, Journal Article)
|
| Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
|
| Topics |
- Adult
- Aged
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage, therapeutic use)
- Arthritis, Rheumatoid
(drug therapy, epidemiology)
- Cardiovascular Diseases
(epidemiology)
- Cohort Studies
- Comorbidity
- Controlled Clinical Trials as Topic
- Female
- Humans
- Incidence
- Male
- Middle Aged
- Prevalence
- Prospective Studies
- Rheumatic Diseases
(drug therapy, epidemiology)
- Risk
- Risk Assessment
- Risk Factors
- Spondylarthropathies
(drug therapy, epidemiology)
- Time Factors
|
